- Home
- CTS vs IMTX Comparison
CTS vs IMTX Comparison
Compare CTS & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTS | IMTX |
|---|---|---|
| Founded | 1896 | N/A |
| Country | United States | Germany |
| Employees | N/A | 407 |
| Industry | Electrical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | CTS | IMTX |
|---|---|---|
| Price | $59.13 | $11.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $19.00 |
| AVG Volume (30 Days) | 215.5K | ★ 319.4K |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | ★ 0.29% | N/A |
| EPS Growth | ★ 15.87 | N/A |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $541,318,000.00 | N/A |
| Revenue This Year | $5.55 | N/A |
| Revenue Next Year | $5.00 | $25.91 |
| P/E Ratio | $101.42 | ★ N/A |
| Revenue Growth | ★ 4.95 | N/A |
| 52 Week Low | $36.03 | $4.93 |
| 52 Week High | $60.82 | $12.41 |
Technical Indicators
Market Signals| Indicator | CTS | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 67.96 | 54.52 |
| Support Level | $41.09 | $9.61 |
| Resistance Level | $59.66 | $11.41 |
| Average True Range (ATR) | 2.11 | 0.50 |
| MACD | 0.29 | -0.04 |
| Stochastic Oscillator | 79.12 | 53.39 |
Price Performance
Historical ComparisonAbout CTS CTS Corporation
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEMs) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China, Singapore, the Czech Republic, Taiwan, Denmark, and other countries.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.